Copenhagen Bioscience Snapshot - Virtual seminar by Lotte Bjerre Knudsen

We are excited to announce the first Copenhagen Bioscience Snapshot of 2020: Dr. Lotte Bjerre Knudsen will give a virtual seminar on May 15. Follow this Microsoft Teams link to join the seminar. Dr. Knudsen is the lead and co-inventor of liraglutide, a GLP1 receptor agonist currently used to treat type 2 diabetes mellitus and obesity. Driven by a passion a passion for discovery and improving patients’ lives, she has extensive experience as a leader in drug development, having led safety and mechanism studies, contributed to numerous patents, served on FDA advisory committees, and is an adjunct professor of Translational Medicine at Aarhus University.